As income investors look toward 2026, a stark choice emerges between Energy Transfer's tempting 7.1% yield and Enterprise Products Partners' quarter-century record of reliable payouts. We examine the risk-reward calculus behind the numbers.
Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.
The affordable cosmetics giant e.l.f. Beauty is poised to release its fourth-quarter financial results this week, following a period of robust stock performance and mixed signals from the broader consumer staples sector.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Nomura Holdings announces a significant share buyback program while tightening risk controls at its digital asset unit, Laser Digital. The move signals a dual focus on immediate capital returns and long-term, regulated growth in the crypto space, as the financial giant navigates a volatile market.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Shares of cybersecurity firm Gen Digital have tumbled over 7% in a week, pushing its valuation metrics below industry averages. A deep dive into its cash flows and earnings multiples suggests the market may be undervaluing the consumer digital safety provider.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
As Equitable Holdings prepares to report fourth-quarter results, investors are watching for signs of stability amid a turbulent period for insurance stocks. With revenue growth expected to stall, the focus shifts to profitability and guidance.
Offshore drilling contractor Noble Corporation bolsters its forward workload with a series of new multi-year contracts totaling approximately $1.3 billion, headlined by a major harsh-environment rig award in Norway, signaling a strategic geographic expansion and renewed confidence in the offshore cycle.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
The global insurer faces heightened scrutiny after a recent revenue miss, with analysts projecting a sharp year-over-year sales increase as peers post mixed results.
Old Dominion Freight Line prepares to release its quarterly results Wednesday morning, with analysts projecting a revenue dip but watching for signs of resilience in a challenging transport market.
Crown Holdings (CCK) is scheduled to report its fourth-quarter earnings after Wednesday's market close, with analysts projecting modest revenue growth and steady profitability as the metal packaging giant navigates shifting demand and competitive pressures.
